hepatitis

graphic image of different colored hands shaking
Biotech

Vir links up with Norgine in €550M hepatitis D licensing deal

Norgine secured an exclusive license to commercialize Vir Biotechnology's hepatitis D prospect in Europe, Australia and New Zealand.
Zoey Becker Dec 17, 2025 12:50pm
Layoffs

nChroma Bio sheds staff in research reorganization

Nov 12, 2025 5:31pm
liver

Bausch Health bags phase 3-ready liver prospect in $63M buyout

Jul 29, 2025 9:35am
green light shining in night

Kezar sees hepatitis hold lifted, mulls restarting lupus program

Jul 16, 2025 8:47am
Signage for the Department of Health and Human Services HHS headquarters is seen on April 02 2025 in Washington DC
Favicon Fierce Healthcare

Judge sides with states, blocking HHS reorg and mass layoffs

Jul 1, 2025 3:30pm
plan B fail reroute road path trail miss

Surrozen drops sole clinical-stage drug over weak hepatitis data

Mar 24, 2025 10:50am